Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops

Molecular Vision

Volumn 18, Issue , 2012, Pages 455-464

  Lennikov, Anton ^a   Kitaichi, Nobuyoshi ^a,b   Fukase, Risa ^a   Murata, Miyuki ^a   Noda, Kousuke ^a   Ando, Ryo ^a   Ohguchi, Takeshi ^a   Kawakita, Tetsuya ^c   Ohno, Shigeaki ^a   Ishida, Susumu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASTAXANTHIN; EOSIN; EYE DROPS; HEMATOXYLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MACROGOL; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA THICKNESS; CYTOTOXICITY; DOWN REGULATION; DRUG ACTIVITY; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KERATITIS; MALE; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; STAINING; ULTRAVIOLET B RADIATION; ULTRAVIOLET INDUCED PHOTOKERATITIS;

ADMINISTRATION, OPHTHALMIC; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; CORNEA; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; IN SITU NICK-END LABELING; KERATITIS; MALE; MICE; MICE, INBRED C57BL; OPHTHALMIC SOLUTIONS; OXIDATIVE STRESS; ULTRAVIOLET RAYS; XANTHOPHYLLS;

EID: 84857807405     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Schein OD. Phototoxicity and the cornea. J Natl Med Assoc 1992; 84:579-83. [PMID: 1629921]
2. Cullen AP, Chou BR, Hall MG, Jany SE. Ultraviolet-B damages corneal endothelium. Am J Optom Physiol Opt 1984; 61:473-8. [PMID: 6465280]
3. Kitaichi N, Shimizu T, Yoshida K, Honda A, Yoshihisa Y, Kase S, Ohgami K, Norisugi O, Makino T, Nishihira J, Yamagishi S, Ohno S. Macrophage migration inhibitory factor ameliorates UV-induced photokeratitis in mice. Exp Eye Res 2008; 86:929-35. [PMID: 18436209]
4. Suzuki Y, Ohgami K, Shiratori K, Jin XH, Ilieva I, Koyama Y, Yazawa K, Yoshida K, Kase S, Ohno S. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway. Exp Eye Res 2006; 82:275-81. [PMID: 16126197]
5. Moreira AJ, Fraga C, Alonso M, Collado PS, Zetller C, Marroni C, Marroni N, Gonzalez-Gallego J. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol 2004; 68:1939-46. [PMID: 15476665]
6. Clark RA, Valente AJ. Nuclear factor kappa B activation by NADPH oxidases. Mech Ageing Dev 2004; 125:799-810. [PMID: 15541774]
7. Shao DZ, Lee JJ, Huang WT, Liao JF, Lin MT. Inhibition of nuclear factor-kappa B prevents staphylococcal enterotoxin A-induced fever. Mol Cell Biochem 2004; 262:177-85. [PMID: 15532722]
8. Woo SH, Park IC, Park MJ, An S, Lee HC, Jin HO, Park SA, Cho H, Lee SJ, Gwak HS, Hong YJ, Hong SI, Rhee CH. Arsenic trioxide sensitizes CD95/Fas-induced apoptosis through ROS-mediated upregulation of CD95/Fas by NF- kappaB activation. Int J Cancer 2004; 112:596-606. [PMID: 15382040]
9. Ohta K, Nakayama K, Kurokawa T, Kikuchi T, Yoshimura N. Inhibitory effects of pyrrolidine dithiocarbamate on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 2002; 43:744-50. [PMID: 11867593]
10. Fassett RG, Coombes JS. Astaxanthin, oxidative stress, inflammation and cardiovascular disease. Future Cardiol 2009; 5:333-42. [PMID: 19656058]
11. Jyonouchi H, Sun S, Tomita Y, Gross MD. Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen. J Nutr 1995; 125:2483-92. [PMID: 7562082]
12. Kobayashi M. In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis. Appl Microbiol Biotechnol 2000; 54:550-5. [PMID: 11092631]
13. Spiller GA, Dewell A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial. J Med Food 2003; 6:51-6. [PMID: 12804020]
14. Chew BP, Park JS, Wong MW, Wong TS. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 1999; 19:1849-53. [PMID: 10470126]
15. Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 2007; 71:893-9. [PMID: 17420580]
16. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 2008; 101:58D-68D. [PMID: 18474276]
17. Choi SK, Park YS, Choi DK, Chang HI. Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J Microbiol Biotechnol 2008; 18:1990-6. [PMID: 19131704]
18. Barrow CJ, Shahidi F. Marine nutraceuticals and functional foods. Boca Raton: CRC Press; 2008.
19. Liu X, Shibata T, Hisaka S, Osawa T. Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism. Brain Res 2009; 1254:18-27. [PMID: 19101523]
20. Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 1990; 22:27-38. [PMID: 2084711]
21. Bennedsen M, Wang X, Willen R, Wadstrom T, Andersen LP. Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol Lett 1999; 70:185-9. [PMID: 10656672]
22. Mortensen A, Skibsted LH, Sampson J, Rice-Evans C, Everett SA. Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett 1997; 418:91-7. [PMID: 9414102]
23. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S. Effects of astaxanthin on lipopolysaccharide- induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 2003; 44:2694-701. [PMID: 12766075]
24. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci 2008; 49:1679-85. [PMID: 18385091]
25. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 2010; 53:971-9. [PMID: 20162412]
26. Okada N, Kawakita T, Mishima K, Saito I, Miyashita H, Yoshida S, Shimmura S, Tsubota K. Clusterin promotes corneal epithelial cell growth through upregulation of hepatocyte growth factor by mesenchymal cells in vitro. Invest Ophthalmol Vis Sci 2011; 52:2905-10. [PMID: 21282577]
27. Kawakita T, Shimmura S, Hornia A, Higa K, Tseng SC. Stratified epithelial sheets engineered from a single adult murine corneal/limbal progenitor cell. J Cell Mol Med 2008; 12:1303-16. [PMID: 18318692]
28. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-79. [PMID: 8011280]
29. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107:135-42. [PMID: 11160126]
30. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175:1181-94. [PMID: 1314883]
31. Németh ZH, Hasko G, Vizi ES. Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, MIP-1alpha, IL-12, and nitric oxide production and protects from the lethal effect of endotoxin. Shock 1998; 10:49-53. [PMID: 9688091]
32. Liu SF, Ye X, Malik AB. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 1999; 100:1330-7. [PMID: 10491379]
33. Lauzurica P, Martinez-Martinez S, Marazuela M, Gomez del Arco P, Martinez C, Sanchez-Madrid F, Redondo JM. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 1999; 29:1890-900. [PMID: 10382751]
34. Schulze-Osthoff K, Los M, Baeuerle PA. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol 1995; 50:735-41. [PMID: 7575632]
35. Muñoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo JM, de Landazuri MO. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF- kappa B and AP-1 transcription factors activity. Blood 1996; 88:3482-90. [PMID: 8896414]
36. Kawada H, Kojima M, Kimura T, Natori S, Sasaki K, Sasaki H. Effect of 5-S-GAD on UV-B-induced cataracts in rats. Jpn J Ophthalmol 2009; 53:531-5. [PMID: 19847611]